Vivanza Biosciences consolidated net profit rises 400.00% in the December 2025 quarter
Sales rise 2916.67% to Rs 45.25 crore
Net profit of Vivanza Biosciences rose 400.00% to Rs 0.20 crore in the quarter ended December 2025 as against Rs 0.04 crore during the previous quarter ended December 2024. Sales rose 2916.67% to Rs 45.25 crore in the quarter ended December 2025 as against Rs 1.50 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var.Sales45.251.50 2917 OPM %0.468.00 -PBDT0.200.05 300 PBT0.200.04 400 NP0.200.04 400Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content